Recurrent Brain Neoplasm
18
1
4
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
5.6%
1 terminated out of 18 trials
91.7%
+5.2% vs benchmark
6%
1 trials in Phase 3/4
55%
6 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (18)
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma